SCHEMBL852464

SCHEMBL852464

COC(=O)C=C(c1cccnc1)c1c[nH]c2ccc(OCCc3cccc(N(C)C(=O)OC(C)(C)C)n3)cc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR4A2 P43354 2/20 0.36
KIF20A O95235 2/20 0.36
DYRK1A Q13627 1/20 0.36
MTNR1A P48039 3/20 0.34
MTNR1B P49286 3/20 0.34
CYP1A2 P05177 4/20 0.34
CYP3A4 P08684 4/20 0.34
CYP2D6 P10635 4/20 0.34
CYP2C19 P33261 4/20 0.34
CLK4 Q9HAZ1 4/20 0.34
USP2 O75604 3/20 0.34
CYP2C9 P11712 2/20 0.34
CPT1A P50416 1/20 0.33
HSD17B10 Q99714 3/20 0.33
ALOX15 P16050 1/20 0.33
PIM1 P11309 1/20 0.33
GAA P10253 1/20 0.33
NAMPT P43490 1/20 0.32
ALDH1A1 P00352 2/20 0.32
LMNA P02545 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL853915 0.86 HTT (0.35) MTNR1AMTNR1BCYP1A2CYP2C19CYP2C9
SCHEMBL854495 0.82 CCKBR (0.35) MTNR1AMTNR1BCYP1A2CYP3A4CYP2D6
SCHEMBL853770 0.79 NR1H2 (0.36) MTNR1AMTNR1BCYP1A2CYP3A4CYP2D6
SCHEMBL2489921 0.78 ITGB3 (0.37) TSHRKMT2A
SCHEMBL861190 0.73 MAOA (0.42) MTNR1AMTNR1B
SCHEMBL853670 0.71 NR1H2 (0.36) MTNR1AMTNR1BGAAMEN1KMT2A
SCHEMBL853983 0.69 ITGB3 (0.35) MTNR1AMTNR1BCYP1A2CYP3A4CYP2D6
SCHEMBL860965 0.68 ITGB3 (0.52)
SCHEMBL852604 0.65 KDM4E (0.42) GAAALDH1A1LMNAMEN1KMT2A
SCHEMBL854074 0.65 ITGB3 (0.39) MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1425010-B8 SUBSTITUTED INDOLES AND THEIR USE AS INTEGRIN ANTAGONISTS JANSSEN PHARMACEUTICALS INC (US) 2012-03-28 EP disclosed
EP-1425010-A4 SUBSTITUTED INDOLES AND THEIR USE AS INTEGRIN ANTAGONISTS ORTHO MCNEIL PHARM INC (US) 2009-07-29 EP disclosed
EP-1425010-A1 SUBSTITUTED INDOLES AND THEIR USE AS INTEGRIN ANTAGONISTS Ortho-McNeil Pharmaceutical, Inc. (US) 2004-06-09 EP disclosed
WO-2002060438-A1 SUBSTITUTED INDOLES AND THEIR USE AS INTEGRIN ANTAGONISTS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2002-08-08 WO disclosed